Intensity Therapeutics 주식 (NASDAQ: INTS)

에 대한 최신 뉴스 Intensity Therapeutics (NASDAQ:INTS) 주식

INTENSITY THERAPEUTICS INC

Intensity Therapeutics

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics Inc

News

Offerings

General

SBET

SharpLink Gaming Announces Private Placement Offering Of ~58.7M Shares Of Common Stock And Pre-Funded Warrants At $6.15 Per Unit; CEO and CFO Participate With $200K Combined Investment

<h3>Gainers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock increased by 6.8% to $0.48 during Friday's after-market session. The company's market cap stands at $9.6 million. </li>
<li>Venu Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VENU#AMEX">VENU</a>) shares moved upwards by 6.55% to $9.98. The market value of their outstanding shares is at $378.3 million. </li>
<li>FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATBP#NASDAQ">FATBP</a>) stock rose 5.8% to $2.37. </li>
<li>GEN Restaurant Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) shares moved upwards by 4.84% to $3.46. The market value of their outstanding shares is at $17.4 million. </li>
<li>Fossil Group, Inc. - 7% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSLL#NASDAQ">FOSLL</a>) stock increased by 4.59% to $16.61. </li>
<li>Fly-E Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) stock increased by 4.38% to $0.51. The market value of their outstanding shares is at $12.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ContextLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGC#NASDAQ">LOGC</a>) stock decreased by 17.3% to $6.78 during Friday's after-market session. The market value of their outstanding shares is at $180.9 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) shares declined by 8.67% to $4.11. The company's market cap stands at $836.6 million. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares declined by 7.7% to $1.32. The market value of their outstanding shares is at $39.8 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares declined by 5.5% to $2.75. The company's market cap stands at $12.5 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares decreased by 4.84% to $73.0. The company's market cap stands at $50.9 million. </li>
<li>High Roller Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ROLR#AMEX">ROLR</a>) stock fell 4.82% to $4.15. The market value of their outstanding shares is at $34.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMST

FATBP

FLYE

Fossil Group, Inc. - 7% Senior Notes due 2026

FOSLL

FTEL

GENK

LOGC

LVWR

ROLR

TLYS

VENU

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares rose 32.5% to $0.38 during Friday's after-market session. The market value of their outstanding shares is at $2.2 million. As per the press release, Q1 earnings came out today. </li>
<li>Kymera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) shares rose 15.99% to $34.38. The market value of their outstanding shares is at $2.2 billion. </li>
<li>Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) stock moved upwards by 10.52% to $16.49. The company's market cap stands at $1.4 billion. </li>
<li>Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) shares moved upwards by 10.16% to $0.66. The market value of their outstanding shares is at $106.8 million. </li>
<li>Rafael Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RFL#NYSE">RFL</a>) stock rose 8.38% to $1.55. The market value of their outstanding shares is at $57.7 million. </li>
<li>Biote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTMD#NASDAQ">BTMD</a>) shares increased by 8.37% to $3.75. The market value of their outstanding shares is at $118.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) stock declined by 29.6% to $0.01 during Friday's after-market session. The market value of their outstanding shares is at $4.6 million. </li>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock fell 15.69% to $4.14. The market value of their outstanding shares is at $3.0 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares decreased by 11.63% to $0.38. The market value of their outstanding shares is at $1.8 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares fell 10.53% to $5.44. The market value of their outstanding shares is at $102.1 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares declined by 8.74% to $0.94. The company's market cap stands at $8.1 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares decreased by 8.44% to $0.44. The market value of their outstanding shares is at $8.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMGL

BTMD

ENTO

INTS

IRWD

KYMR

LGMK

LQDA

PSTV

RSLS

SLXN

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>JFB Construction (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFB#NASDAQ">JFB</a>) shares rose 17.0% to $6.55 during Friday's after-market session. The market value of their outstanding shares is at $60.5 million. </li>
<li>Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) shares moved upwards by 6.53% to $0.88. The market value of their outstanding shares is at $137.3 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares moved upwards by 5.44% to $0.32. The company's market cap stands at $8.4 million. </li>
<li>OneConstruction Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEG#NASDAQ">ONEG</a>) shares rose 5.12% to $3.49. The market value of their outstanding shares is at $45.3 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares moved upwards by 5.0% to $0.49. The company's market cap stands at $15.4 million. </li>
<li>TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) shares increased by 4.99% to $6.3. The company's market cap stands at $187.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) stock decreased by 8.4% to $1.64 during Friday's after-market session. The market value of their outstanding shares is at $84.1 million. </li>
<li>OFA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) shares declined by 7.65% to $4.71. The market value of their outstanding shares is at $62.9 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock declined by 6.16% to $0.37. The company's market cap stands at $6.6 million. </li>
<li>Eve Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVEX#NYSE">EVEX</a>) shares decreased by 5.56% to $5.1. The company's market cap stands at $1.5 billion. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares decreased by 5.17% to $3.12. The company's market cap stands at $8.4 million. </li>
<li>NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) shares decreased by 5.17% to $2.02. The market value of their outstanding shares is at $157.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EVEX

HTOO

ILAG

NPWR

NRGV

OFAL

ONEG

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) stock rose 77.2% to $0.49 during Friday's after-market session. The market value of their outstanding shares is at $20.4 million. </li>
<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) shares increased by 11.76% to $1.14. The market value of their outstanding shares is at $9.3 million. </li>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares increased by 5.0% to $0.67. The company's market cap stands at $35.9 million. </li>
<li>Thumzup Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) stock moved upwards by 4.98% to $8.63. The company's market cap stands at $82.0 million. </li>
<li>WM Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) stock moved upwards by 4.78% to $1.09. The market value of their outstanding shares is at $114.4 million. </li>
<li>Maris Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEK#NASDAQ">MTEK</a>) shares rose 4.62% to $2.26. The company's market cap stands at $17.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock declined by 9.2% to $1.09 during Friday's after-market session. The market value of their outstanding shares is at $79.0 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock fell 4.49% to $2.98. The market value of their outstanding shares is at $4.5 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) stock fell 4.42% to $0.65. The market value of their outstanding shares is at $5.8 million. </li>
<li>BIO-key International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) stock fell 3.58% to $0.81. The company's market cap stands at $4.7 million. </li>
<li>Interlink Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINK#NASDAQ">LINK</a>) shares declined by 3.26% to $6.25. The market value of their outstanding shares is at $61.6 million. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) stock decreased by 3.01% to $0.91. The market value of their outstanding shares is at $4.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASNS

BKYI

BNAI

GRYP

IFBD

LINK

MAPS

MOBX

MTEK

PRSO

SOBR

TZUP

12 Information Technology Stocks Moving In Friday's After-Market Session

OAKU

Oak Woods Acquisition Receives Nasdaq Deficiency Letter Regarding Delayed Filing of Quarterly Report on Form 10-Q

In the current market session, Antero Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) stock price is at $37.45, after a 3.58% decrease. However, over the past month, the company's stock went up by 4.73%, and in the past year, by 6.66%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1748638872_0.png" alt="Past Year Chart" />

<h3>Evaluating Antero Resources P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Antero Resources has a better P/E ratio of 50.44 than the aggregate P/E ratio of 17.75 of the Oil, Gas &amp; Consumable Fuels industry. Ideally, one might believe that Antero Resources Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748638872_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

A Look Into Antero Resources Inc's Price Over Earnings

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) has outperformed the market over the past 5 years by 7.84% on an annualized basis producing an average annual return of 21.69%. Currently, JPMorgan Chase has a market capitalization of $733.68 billion. 
Buying $1000 In JPM: If an investor had bought $1000 of JPM stock 5 years ago, it would be worth $2,677.48 today based on a price of $264.00 for JPM at the time of writing.
<h3>JPMorgan Chase's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748638817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

IVDA

Iveda Solutions Receives Non-Compliance Notice From Nasdaq

ReShape Lifesciences Entered Into Equity Distribution Agreement Relating To Sale Of Up To $9.7M Of Shares Of Common Stock

GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) has outperformed the market over the past 5 years by 81.59% on an annualized basis producing an average annual return of 95.44%. Currently, GameStop has a market capitalization of $13.30 billion. 
Buying $100 In GME: If an investor had bought $100 of GME stock 5 years ago, it would be worth $2,886.20 today based on a price of $29.74 for GME at the time of writing.
<h3>GameStop's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748637912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

MGRX

Mangoceuticals Files For Resale Up To 4.5M Shares Of Common Stock By Selling Shareholders

LUCD

Lucid Diagnostics May Offer Sell Shares Of Common Stock Of Up To $25M

MNSB

MainStreet Bancshares Says Determined To Report Information Related To A Data Security Incident Which It Has Been Investigating; In March 2025, Company Was Made Aware That An Outside Vendor To Core Bank Had Been Compromised; Compromised Vendor System Included 4.65% Of Customer Data

ContextLogic To Delist From The Nasdaq; Co. Set To Begin Trading On The OTC Markets On June 3, 2025

Brag House Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBH#NASDAQ">TBH</a>), the Gen Z engagement platform at the intersection of gaming, college sports, and digital media, today announced that it continues to diligently work on its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025.
As anticipated, on May 27, 2025, the Company received notice from the Nasdaq Stock Market that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-Q. Brag House intends to file its Form 10-Q before the date it would have to submit a compliance plan on July 28 to Nasdaq for continued listing. The Nasdaq notice has no immediate effect on the listing or trading of Brag House's common stock on the Nasdaq Capital Market.

Brag House Holdings Says Working To File Delayed Q1 2025 10-Q; Receives Nasdaq Noncompliance Notice Aims To Meet July 28 Deadline

A new report of the most-viewed television series in the 2024-2025 season shows Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) and Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>) as winners across broadcast television and<a href="https://www.benzinga.com/topic/streaming"> the streaming sector.</a>
What Happened: Data from Nielsen that tracks 35 days of viewership across traditional television, cable and streaming — without including sports — shows Netflix the streaming leader and Paramount <a href="https://www.benzinga.com/general/entertainment/25/05/45363944/cbs-highlights-tv-dominance-17-year-streak-on-top-can-success-help-offset-trump-merger-concerns">the broadcast leader.</a>
Here are the top 10 most-viewed shows during the time period, as reported by <a href="https://variety.com/2025/tv/news/most-popular-tv-shows-2024-25-squid-game-adolescence-1236412566/">Variety</a>, with their average viewership.
<ol class="wp-block-list">
<li>&#8220;Squid Game,&#8221; Netflix: 27.1 million</li>
<li>&#8220;Adolescence,&#8221; Netflix: 19.0 million</li>
<li>&#8220;Tracker,&#8221; CBS: 17.4 million</li>
<li>&#8220;Reacher,&#8221; Prime Video: 17.4 million</li>
<li>&#8220;High Potential,&#8221; ABC: 16.1 million</li>
<li>&#8220;Matlock,&#8221; CBS: 16.0 million</li>
<li>&#8220;Landman,&#8221; Paramount+, 15.8 million</li>
<li>&#8220;Monsters: The Lyle and Erik Menendez Story,&#8221; Netflix: 15.7 million</li>
<li>&#8220;Zero Day,&#8221; Netflix: 15.7 million</li>
<li>&#8220;Nobody Wants This,&#8221; Netflix: 15.2 million</li>
</ol>
Netflix dominated the list with five of the top 10. The streaming giant also had numbers 11, 12, 13, 14 and 15 on the list giving it 10 of the top 15. Overall, Netflix had 12 of the top 25 series.
Paramount ranked second with three of the top 10. The company also had 16, 17 and 21 on the list, good for six of the top 25 series.
Outside of these two, Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) had "High Potential" at fifth place. The series had split viewership between ABC and Hulu, according to the report.
Prime Video from Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) had the fourth most-watched title in "Reacher." This was the only top 25 title for Amazon with its next best ranked 42nd and other hits like "Beast Games" ranking 73rd on the list, with only viewers available from streaming and not multiple platforms.
Read Also: <a href="https://www.benzinga.com/general/entertainment/25/05/45676520/is-paramount-offering-millions-to-trump-to-end-60-minutes-lawsuit-report-says-opening-offer-has-been-made">Is Paramount Offering Millions To Trump To End &#8217;60 Minutes&#8217; Lawsuit? Report Says &#8216;Opening Offer Has Been Made&#8217;</a>
Why It's Important: The rankings also show average viewership for the key age 18 to 49 demographic, which shows an even larger dominance from Netflix.
Netflix had six of the top 10 series for the 18 to 49 age demographic with "Squid Game," "Adolescence," "Monsters," "Nobody Wants This," "Running Point" and "Ms. Rachel." The streaming giant had 17 of the top 25 shows for viewership in this key age demographic.
For Paramount, the results were much different as the company only had one title rank in the top 10 for the key age demographic with "Landman." Unlike other series that air on CBS and stream on Paramount+, "Landman" is a streaming exclusive title.
Paramount's next highest title on the 18 to 49 chart is "Mobland" at 30.
This means Paramount is getting much higher viewership from its broadcast segment (CBS) than from its streaming. It also shows the balance of the company having a strong network and streaming platform with positions on both top 10 lists. This also illustrates Paramount is one of the winners in having series that appeal to all ages, including the 50+ demographic.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/entertainment/25/05/45524031/n-is-for-netflix-streamer-to-show-viewers-how-to-get-to-sesame-street">N Is For Netflix: Streamer To Show Viewers How To Get To &#8216;Sesame Street&#8217;</a></li>
</ul>
Photos: Shutterstock

Entertainment

AMZN

NFLX

PARA

PARAA

Netflix, Paramount Dominate New Top Series Viewers: How Streaming, Connection With Different Age Demographics Helps

A new study from the Society of Economic Geologists (SEG) warns that copper prices will need to more than double if the world is to produce enough of the metal to support the <a href="https://www.benzinga.com/topic/renewable-energy">global energy transition</a>.
The <a href="https://pubs.geoscienceworld.org/segweb/segdiscovery/article/doi/10.5382/SEGnews.2025-141.fea-01/654182/Copper-Mining-Development-and-Electrification">research paper</a> by Cathles, Simon and Wood reveals that current and anticipated copper production falls far short of the demands imposed by both continued global development and decarbonization efforts. These experts from Cornell University, the University of Michigan, and the University of Queensland argue that unless prices rise substantially to incentivize new mining, the energy transition will stall—crippled by a fundamental material shortfall.
Even in the "business-as-usual" demand scenario, which excludes the impacts of electrification and focuses solely on expected growth from rising global incomes and population, the mined copper output must increase from 20.4 million tons per year in 2018 to 37.1 million tons per year by 2050. Such growth would require adding over half a million tons of new capacity each year —a challenge equivalent to commissioning 36 large new mines or 759 smaller ones within just three decades.
Given that large copper mines often take more than 20 years to develop from discovery to production, the authors deem this outcome improbable. Five of the current top ten mines are expected to close by 2050, and many smaller mines <a href="https://www.benzinga.com/25/04/44682458/coppers-rout-sees-a-massive-intraday-price-swing-fundamentals-havent-changed-expert-says">will follow suit</a>.
However, mining economics notably worsen the picture. The rising development cost means that brownfield projects now require around $23,000 per ton of added annual production capacity. Since copper prices generally track capital intensity one-to-one, the authors conclude that "the future copper price must exceed $20,000 per ton" to make new development viable. At today's price of roughly $9,600, that means copper prices must more than double just to enable supply to meet projected demand.
Yet, those problems seem minuscule in comparison to supply problems when considering electrification and energy transition, especially the demand from wind and solar energy generation. If those two sources of energy were to dominate the power mix, annual copper mining would have to increase by 22.5 large new mines per year on average between 2018 and 2035.
"Deposits cannot be discovered and mines cannot be developed at this rate," the authors noted. In this scenario, more copper would be mined by 2050 than in all previous human history combined, with over half of the known copper endowment exhausted in just three decades.
The International Energy Agency <a href="https://www.iea.org/news/ai-is-set-to-drive-surging-electricity-demand-from-data-centres-while-offering-the-potential-to-transform-how-the-energy-sector-works">report</a> warns that the world is closer to the second scenario than the first one. According to the latest research, global electricity use from AI data centers is expected to more than double by 2030, reaching approximately 945 terawatt-hours (TWh), surpassing the current power consumption of Japan. With the rise of AI, demand for clean, reliable electricity is skyrocketing. Yet building solar- and wind-heavy grids capable of supporting AI's loads would significantly increase the need for copper-intensive grid infrastructure and storage.
The SEG study also highlights a global equity issue. Developing countries require approximately 1,043 million tons of copper to achieve infrastructure levels comparable to those in high-income nations. That is equivalent to 50 years of current global copper production. Thus, a copper shortage problem and a price bidding war could result in resource hoarding, diverting the metal away from the developing world's growth.
"Society can have a win-win solution or a fail-fail solution. For a win-win outcome, the copper needs of the electrical transition must be nearly completely eliminated," the research said.
To ensure copper is available for both electrification and human development, strategies that minimize copper use, such as nuclear power, methane backup plants, and hybrid vehicles, must be a priority, scientists concluded.
Price Watch: iShares Copper and Metals Mining ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICOP#NASDAQ">ICOP</a>) is up 9.52% year-to-date.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/rumors/25/05/45693244/glencores-restructuring-sets-stage-for-mining-mega-merger">Glencore&#8217;s Restructuring Sets Stage For Mining Mega-Merger</a></li>
</ul>
Photo by TimBrew via Shutterstock.

Commodities

ICOP

Energy Goals Are Impossible Without Copper Price Surge, Study Shows

<a href="https://www.cnbc.com/halftime/" title="https://www.cnbc.com/halftime/">https://www.cnbc.com/halftime/</a>

UPDATE: Today On CNBC Halftime Report, Josh Brown Changed Final Trade From Netflix To JP Morgan Chase & Co.

9F Inc Receives Nasdaq Letter Regarding Late Filing of Form 20-F

Press Releases

Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement

Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial, INVINCIBLE-4 (SAKK 66/22), at the 2024 San Antonio Breast Cancer Symposium (SABCS)

Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6

Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review

Earnings

Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update

Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering

Small Cap

Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Receive European Medicines Agency Authorization to Initiate Phase 2 INVINCIBLE-4 (SAKK/66/22) Study for INT230-6 in the Treatment of Presurgical Triple-Negative Breast Cancer in France

Intensity Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment Options on the Horizon

Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

Comments

Intensity Therapeutics

뉴스

에 대한 최신 뉴스 Intensity Therapeutics (NASDAQ:INTS) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌